THE FUNCTIONAL CAPATACI OF THE RESPIRATORY AND CARDIOVASCULAR SYSTEMS OF PEOPLE LIVING WITH HIV AT THE STAGE OF AIDS AND THE PROSPECTS FOR ITS IMPROVEMENT BY METHODS AND MEANS OF PHYSICAL THERAPY
DOI:
https://doi.org/10.32782/2522-1795.2022.13.7Keywords:
HIV, PLHIV, functional capacity.Abstract
Objective: to study the functional capacity of the respiratory and cardiovascular systems of PLWH at the stage of AIDS to choose a rational training program. Materials: The study included 24 HIV-infected patients at the stage of AIDS on an outpatient basis. To assess the functional capacity (FC) of the respiratory system, the following were determined: breathing rate (BR), SpO2, Stange and Genchi tests, vital capacity of the lungs (VCL). The hypoxia index (HI), the Hildebrant coefficient (HC) and the circulatory-respiratory coefficient of Skibinskaya (CRCS) were calculated. Studying the FC of the cardiovascular system determined heart rate (HR), blood pressure (BP), pulse pressure (PP), systolic (SBV) and minute (MBV) blood volumes. The coefficients of efficiency of blood circulation (CEBC), endurance (CE), Robinson index (RI) were also calculated. All PLWH were diagnosed with HIV viral load and CD4+ T lymphocyte counts. Results. Two research groups were formed. It was established that the BH was 19.7 ± 1.9 per minute and 21.1 ± 1.8 (p≤0.05) per minute in groups I and II, respectively. SpO2 level, was lower in group I 91.5 ± 1.6 % against 93.2 ± 1.9 % in group II (p≤0.05). In group I, the result of the Genchi test was 32.2 ± 2.7 sec., the Stange – 31.3 ± 5.2 sec. For group II, the data were similar: 29.7 ± 4.3 sec. and 32.2 ±6.6 sec. respectively (p≥0.05). VCL in PLWH group I reached 2639.1 ± 430.3 ml, and in group II – 3144.5 ± 463.3 ml (p≤0.01). IG in group I 0.41 ± 0.05 с. u. and in group II 0.39 ± 0.07 с. u. (p≥0.05). The value of HC is the same in two groups – 3.97 ±0.3 с. u. for group I and 3.98 ± 0.5 с. u. for group II (p≥0.05). The CRCS was lower in Group I 10.91 ± 3.95 с. u. against 13.64 ± 4.81 с. u. in group II (p≥0.05). Studying the FC of the cardiovascular system for group I, it was established: HR 78.4 ± 6.8 bpm, SBP 126.3 ± 14.5 mmHg, DBP 71.3 ± 9.2 mmHg, PP 55.0 ± 14.3 mmHg. In group II, HR was 77.3 ± 7.4 bpm, SBP 123.8 ± 18.2 mmHg, DBP 73.1 ± 7.2 mmHg, PP 50.7 ± 18.3 mmHg. (p≥0.05). MBV and SBV in group I patients were 4302.5 ± 827.8 mL and 55.2 ± 11.4 mL, respectively. And in group II: MBV 4342.0 ± 1250.3 ml and SBV 52.01 ± 12.2 ml (p≥0.05). For group I, the CEBC was 4274.5 ± 1011.1 с. u. and 4217.6 ± 1707.8 с. u. for group II (r≥0.05). CE was higher in group II – 19.1 ± 9.7 с. u., against – 16.3 ± 4.7 с. u. (p≥0.05). The RI reached 98.7 ± 11.01 с. u. and 102.46 ± 17.3 с. u. in groups I and II, respectively. Conclusion. The FC of the respiratory and cardiovascular systems in PLWH is very weak and is characterized by low potential with poor compensatory capacity.
References
Brown, K., Williams, D. B., Kinchen, S., Saito, S., Radin, E., Patel, H. et al. Status of HIV epidemic control among adolescent girls and young women aged 15–24 years–seven African countries, 2015–2017. Morbidity and Mortality Weekly Report. 2018. Vol. 67. № 1. Р. 29.
Farahani, M., Mulinder, H., Farahani, A., & Marlink, R. (2017). Prevalence and distribution of non-AIDS causes of death among HIVinfected individuals receiving antiretroviral therapy: a systematic review and metaanalysis. International journal of STD & AIDS. Vol. 28. № 7. Р. 636-650. 3. Vos, A. G., Dodd, C. N., Delemarre, E. M., Nierkens, S., Serenata, C., Grobbee, D. E. et al. Patterns of Immune Activation in HIV and Non HIV Subjects and Its Relation to Cardiovascular Disease Risk. Frontiers in Immunology, 2021. Vol. 12.
Gondim, M. V., Sherrill-Mix, S., Bibollet- Ruche, F., Russell, R. M., Trimboli, S., Smith, A. G. et al. Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption. Science translational medicine. 2021. Vol. 13. № 576. Р. 8179.
Swindells, S., Andrade-Villanueva, J. F., Richmond, G. J., Rizzardini, G., Baumgarten, A., Masiá, M. et al. Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression. New England Journal of Medicine. 2020. Vol. 382. № 12. P. 1112-1123.
Bigna, Jean Joel, et al. Global burden of hypertension among people living with HIV in the era of increased life expectancy: a systematic review and meta-analysis. Journal of Hypertension. 2020. Vol. 38. № 9. Р. 1659-1668.
Bonato, Matteo, et al. The role of physical activity for the management of sarcopenia in people living with HIV. International Journal of Environmental Research and Public Health. 2020. Vol. 17. № 4. P. 1283.
Kodama, Satoru, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. Jama. 2009. Vol. 301. № 19. Р. 2024-2035.
Gomes Neto, Mansueto, et al. Effects of combined aerobic and resistance exercise on exercise capacity, muscle strength and quality of life in HIV-infected patients: a systematic review and meta-analysis. PloS one. 2015. Vol. 10. № 9. e0138066.
O’Brien, Kelly K., et al. Examining the impact of a community-based exercise intervention on cardiorespiratory fitness, cardiovascular health, strength, flexibility and physical activity among adults living with HIV: a three-phased intervention study. PloS one. 2021. Vol. 16. № 9. e0257639.
Ozemek, Cemal, Kristine M. Erlandson, and Catherine M. Jankowski. Physical activity and exercise to improve cardiovascular health for adults living with HIV. Progress in cardiovascular diseases. 2020. Vol. 63. № 2. Р. 178-183.
Chang AY, Rwebembera J, Bendavid E, et al. Clinical Outcomes, Echocardiographic Findings, and Care Quality Metrics for People Living With Human Immunodeficiency Virus (HIV) and Rheumatic Heart Disease in Uganda. Clin Infect Dis. 2022. Vol. 74. № 9. Р. 1543-1548. doi:10.1093/cid/ciab681
Tseng, Zian H., et al. Sudden cardiac death and myocardial fibrosis, determined by autopsy, in persons with HIV. New England Journal of Medicine. 2021. Vol. 384. № 24. Р. 2306-2316.
Seidenberg, Phil, et al. The etiology of pneumonia in HIV-infected Zambian children: findings from the Pneumonia Etiology Research for Child Health (PERCH) Study. The Pediatric infectious disease journal. 2021. Vol. 40. № 9. P. 50.
Madonna, Rosalinda, et al. Exercise- Induced Pulmonary Hypertension Is Associated with High Cardiovascular Risk in Patients with HIV. Journal of clinical medicine. 2022. Vol. 11. № 9. P. 2447.
Githinji, Leah, and Heather J. Zar. Respiratory Complications in Children and Adolescents with Human Immunodeficiency Virus. Pediatric Clinics. 2021. Vol. 68. № 1. Р. 131-145.
Gomes-Neto, Mansueto, et al. Effects of exercise interventions on aerobic capacity and health-related quality of life in people living with HIV/AIDS: systematic review and network meta-analysis. Physical therapy. 2021. Vol. 101. № 7. pzab092.
Rouzaud, C., et al. Lung Transplantation in HIV Patients. The Journal of Heart and Lung Transplantation. 2022. Vol. 41. № 4. Р. 531-532.
Louwrens, Anisca, et al. Age-related differences in the vascular function and structure of South Africans living with HIV. Southern African Journal of HIV Medicine. 2022. Vol. 23. № 1. P. 1335.
Fiseha, Temesgen, et al. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia. PloS one. 2021. Vol. 16. № 4. e0250328.
Collins, Lauren F., Ruth O. Adekunle, and Emily J. Cartwright. Metabolic syndrome in HIV/HCV co-infected patients. Current treatment options in infectious diseases. 2019. Vol. 11. № 4. Р. 351-371.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.